[Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas].
Gennigens C, Jerusalem G.
Rev Med Liege · journal article PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för pazopanib hydrochloride. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
19 träffarPhase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors.
Burris HA, Dowlati A, Moss RA, Infante JR, Jones SF, Spigel DR, Levinson KT, Lindquist D, Gainer SD, Dar MM, Suttle AB, Ball HA, Tan AR.
Mol Cancer Ther · research support, non-u.s. gov't; multicenter study; clinical trial, phase i; journal article · DOI 10.1158/1535-7163.mct-11-0997Pazopanib for the treatment of metastatic renal cell carcinoma.
Pick AM, Nystrom KK.
Clin Ther · review; journal article · DOI 10.1016/j.clinthera.2012.01.014Tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Författaruppgift saknas
Drug Ther Bull · review; journal article · DOI 10.1136/dtb.2011.02.0069[Pharmacological sheet: pazopanib (Votrient), oral administration].
Författaruppgift saknas
J Pharm Belg · journal articlePazopanib for the treatment of renal cancer.
Al-Marrawi MY, Rini B.
Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2011.571206Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal article · DOI 10.1358/mf.2010.32.9.1563109Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal article · DOI 10.1358/mf.2010.32.5.1520420Pazopanib: an oral multitargeted tyrosine kinase inhibitor for use in renal cell carcinoma.
LaPlant KD, Louzon PD.
Ann Pharmacother · review; journal article · DOI 10.1345/aph.1m251Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping.
Li Y, Liu DQ, Yang S, Sudini R, McGuire MA, Bhanushali DS, Kord AS.
J Pharm Biomed Anal · comparative study; journal article · DOI 10.1016/j.jpba.2010.01.043Pazopanib.
Bukowski RM, Yasothan U, Kirkpatrick P.
Nat Rev Drug Discov · news · DOI 10.1038/nrd3073Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal articlePazopanib: therapeutic developments.
Limvorasak S, Posadas EM.
Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656560903436493Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal articleGateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal articleAnalytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
Liu DQ, Chen TK, McGuire MA, Kord AS.
J Pharm Biomed Anal · journal article · DOI 10.1016/j.jpba.2009.04.002Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.
Takahashi K, Saishin Y, Saishin Y, King AG, Levin R, Campochiaro PA.
Arch Ophthalmol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1001/archophthalmol.2009.27Gateways to Clinical Trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · journal articleGateways to clinical trials.
Bayes M, Rabasseda X, Prous JR.
Methods Find Exp Clin Pharmacol · bibliography; journal article